News

Find News

Filter articles

Showing 101 to 110 of 3079 results

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

US02-07-2020Rory O'Neill

Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.

Glenmark becomes fifth generic to be charged with US antitrust violations

02-07-2020Muireann Bolger

Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

Chiesi blocks Japanese drugmaker’s new brand at EU General Court

EU01-07-2020

Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Labrador drops BioFire suit after COVID-19 revelation

30-06-2020

Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

J&J wants $25m over ‘contaminated’ fake medical tools

US29-06-2020

Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.

LSPN Connect: MPP chief wants COVID-19 role

26-06-2020Rory O'Neill

The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

English appeals court refuses Neurim injunction for insomnia drug

UK26-06-2020

The English Court of Appeal has rejected Neurim’s attempt to block sales of a generic version of its insomnia drug made by Mylan ahead of a patent infringement trial. 

Latham recruits two from Hogan Lovells

25-06-2020

Latham & Watkins has added two life sciences-focused litigators, Arlene Chow and Ernest Yakob, to its New York office.

Gilead expands oncology business with Pionyr deal

US25-06-2020Mergers & acquisitions

Gilead Sciences has begun a potential takeover of Pionyr Immunotherapeutics after it agreed to pay $275 million for a 49.9% equity stake in the cancer research company.

Kymab victorious before UK Supreme Court in Regeneron appeal

UK24-06-2020Sarah Morgan

The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice. 

Showing 101 to 110 of 3079 results

LSIPR